What is General Biosystems?
General Biosystems, Inc. is a specialized provider of molecular biology services, focusing on custom oligo and gene synthesis, plasmid DNA preparation, and protein design. The company's offerings are engineered to support high-throughput gene synthesis and biosystem optimization, with a particular emphasis on enhancing protein expression and solubility. Their work is critical for clients engaged in gene regulation and metabolic engineering, underpinning advancements in these scientific fields.
How much funding has General Biosystems raised?
General Biosystems has raised a total of $26K across 1 funding round:
Debt
$26K
Debt (2021): $26K with participation from PPP
Key Investors in General Biosystems
PPP
Public-Private Partnership
What's next for General Biosystems?
With the recent substantial expansion capital, General Biosystems is poised for significant growth. This funding is expected to accelerate the scaling of their molecular biology services, potentially enabling further innovation in custom synthesis and biosystem optimization. The company's strategic focus on supporting complex applications in gene regulation and metabolic engineering suggests a trajectory aimed at solidifying its position as a key partner for research and development in the life sciences sector.
See full General Biosystems company page
